findmyKOL

Hemasri Tokala, MD

Basic profile

Western Michigan University

ORCIDNPI
RegionKalamazoo, MI · MidwestSpecialtyHematology / OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Hemasri Tokala is an Oncology physician affiliated with Western Michigan University. OpenAlex indexes 22 publications with 241 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
22publications

Distinct works indexed by OpenAlex, matched via ORCID.

241citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Musculoskeletal

    61.5%
    RANK Ligand Inhibitor61%
    Denosumab100%
    Part B, office-administered16 patients
    Xanthine oxidase inhibitor0.4%
    Allopurinol100%
    Part D<11 patients
  • Sensory organs

    22.5%
    Corticosteroid22.5%
    Dexamethasone sodium phosphate95%Dexamethasone5%
    Part D + Part B18 patients
  • Cancer & immunology

    12%
    Aromatase Inhibitor5.1%
    Anastrozole75%Letrozole14%Exemestane12%
    Part D<11 patients
    Thalidomide Analog2.5%
    Lenalidomide51%Revlimid49%
    Part D<11 patients

    + 3 more classes in this area

Where care is delivered (Part B)0.3% facility · 99.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”